CMG
57
-3
WU
12
-2
INTC
41
8
TJX
44
2
FSLR
58
3
BA
39
4
MAR
48
-3
AVGO
66
2
GE
70
2
KR
40
-2
AMAT
59
4
ADI
60
3
JNPR
59
-3
HRB
45
-2
WHR
79
2
EIX
34
3
DE
68
8
PRU
50
2
HP
67
-8
CVX
40
3
CMG
57
-3
WU
12
-2
INTC
41
8
TJX
44
2
FSLR
58
3
BA
39
4
MAR
48
-3
AVGO
66
2
GE
70
2
KR
40
-2
AMAT
59
4
ADI
60
3
JNPR
59
-3
HRB
45
-2
WHR
79
2
EIX
34
3
DE
68
8
PRU
50
2
HP
67
-8
CVX
40
3
Financhill
Back

Aligos Therapeutics Stock Predictions

Free Access to "King of the Quants" Stock Rating System

[Claim Your 3 Free Grades Now]
Sell
44

ALGS
Aligos Therapeutics

Last Price:
$34.15
Seasonality Move:
-27%

7 Day Trial

ALL ACCESS PASS

$ 7

Access "King of the Quants" Stock Rating System FREE!

[Claim Your 3 Free Grades Now]

Aligos Therapeutics Stock Forecast

  • Over the next 52 weeks, Aligos Therapeutics has on average historically fallen by 31% based on the past 4 years of stock performance.
  • Aligos Therapeutics has fallen lower in 3 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%
  • Is Aligos Therapeutics Stock Undervalued?
    The current Aligos Therapeutics [ALGS] share price is $34.24. The Score for ALGS is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • ALGS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Aligos Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Aligos Therapeutics has on average historically fallen by 31% based on the past 4 years of stock performance.

Aligos Therapeutics Stock Rating

Sell
44
Aligos Therapeutics (ALGS) is a Sell

Is Aligos Therapeutics overpriced?

  • Aligos Therapeutics has fallen lower in 3 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%

Aligos Therapeutics Stock Price History

Is ALGS stock going to rise?

  • The current trend is relatively stagnant and ALGS is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
aligos.com

52-Week Data

52-Week High:
46.80
52-Week Low:
6.76

Prediction Charts

Market Cap:
122.8M
Price in USD:
34.24
Volume:
221.4K
Beta:
2.52

Technical Analysis

SMA50:
28.75
SMA100:
19.41
SMA200:
17.48
52-Wk Change:
98.49%

Stock Predictions

  • Is Aligos Therapeutics stock public?
    Yes, Aligos Therapeutics is a publicly traded company.
  • What is the Aligos Therapeutics stock quote today?
    The Aligos Therapeutics stock price is 34.24 USD today.
  • How to buy Aligos Therapeutics stock online?
    You can buy Aligos Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-27 43.00 41.15 44.39 39.54
Dec-30 39.88 40.47 41.14 37.06
Dec-31 41.15 39.84 41.30 34.53
Jan-2 40.45 39.82 42.25 38.00
Jan-3 40.35 43.42 44.30 40.30
Jan-6 44.50 45.62 46.80 42.50
Jan-7 46.25 40.92 46.32 40.56
Jan-8 40.13 38.39 40.81 36.36
Jan-10 36.09 33.71 37.12 28.10
Jan-13 32.08 34.34 35.00 31.00
Jan-14 35.04 30.05 35.30 29.35
Jan-15 30.84 31.73 33.44 30.84
Jan-16 32.01 31.61 32.43 30.31
Jan-17 32.89 34.24 34.34 31.50

Aligos Therapeutics Earnings

Aligos Therapeutics Earnings Report: Per Share Aligos Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Aligos Therapeutics Forecast Revenue Growth

Aligos Therapeutics Stock Analysis: Historical quarterly revenues per share for Aligos Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $2.65 per share, and a decrease next year of $0.14 per share.

* Aligos Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.